65.24 USD
-1.33 (-2%)
LNTH gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making LNTH a very profitable company, without any liquidiy or solvency issues. LNTH may be a bit undervalued, certainly considering the very reasonable score on growth With these ratings, LNTH could be worth investigating further for value and quality investing!.
1. Profitability
1.1 Basic Checks
LNTH had positive earnings in the past year.
In the past year LNTH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: LNTH reported negative net income in multiple years.
LNTH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
LNTH has a better Return On Assets (7.37%) than 88.77% of its industry peers.
LNTH has a Return On Equity of 14.98%. This is amongst the best in the industry. LNTH outperforms 90.91% of its industry peers.
LNTH's Return On Invested Capital of 13.60% is amongst the best of the industry. LNTH outperforms 94.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LNTH is significantly above the industry average of 8.82%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.37% | ||
| ROE | 14.98% | ||
| ROIC | 13.6% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
1.3 Margins
LNTH's Profit Margin of 10.99% is amongst the best of the industry. LNTH outperforms 85.56% of its industry peers.
In the last couple of years the Profit Margin of LNTH has grown nicely.
The Operating Margin of LNTH (22.63%) is better than 94.12% of its industry peers.
In the last couple of years the Operating Margin of LNTH has grown nicely.
LNTH has a better Gross Margin (62.23%) than 63.10% of its industry peers.
LNTH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.63% | ||
| PM (TTM) | 10.99% | ||
| GM | 62.23% |
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LNTH is creating value.
The number of shares outstanding for LNTH remains at a similar level compared to 1 year ago.
LNTH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LNTH has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.15 indicates that LNTH is not in any danger for bankruptcy at the moment.
The Altman-Z score of LNTH (4.15) is better than 75.94% of its industry peers.
LNTH has a debt to FCF ratio of 1.37. This is a very positive value and a sign of high solvency as it would only need 1.37 years to pay back of all of its debts.
The Debt to FCF ratio of LNTH (1.37) is better than 90.37% of its industry peers.
LNTH has a Debt/Equity ratio of 0.51. This is a neutral value indicating LNTH is somewhat dependend on debt financing.
LNTH has a Debt to Equity ratio (0.51) which is in line with its industry peers.
Although LNTH does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.51 | ||
| Debt/FCF | 1.37 | ||
| Altman-Z | 4.15 |
ROIC/WACC1.69
WACC8.06%
2.3 Liquidity
LNTH has a Current Ratio of 2.67. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.67, LNTH perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
LNTH has a Quick Ratio of 2.49. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
LNTH has a Quick ratio of 2.49. This is comparable to the rest of the industry: LNTH outperforms 59.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.67 | ||
| Quick Ratio | 2.49 |
3. Growth
3.1 Past
The earnings per share for LNTH have decreased strongly by -14.12% in the last year.
The Earnings Per Share has been growing by 42.10% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 1.95% in the past year.
The Revenue has been growing by 34.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-14.12%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-25.29%
Revenue 1Y (TTM)1.95%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%1.39%
3.2 Future
LNTH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.96% yearly.
The Revenue is expected to grow by 5.41% on average over the next years.
EPS Next Y-15.93%
EPS Next 2Y-8.73%
EPS Next 3Y-0.06%
EPS Next 5Y2.96%
Revenue Next Year-1.03%
Revenue Next 2Y0.1%
Revenue Next 3Y4.21%
Revenue Next 5Y5.41%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.95, the valuation of LNTH can be described as very reasonable.
LNTH's Price/Earnings ratio is rather cheap when compared to the industry. LNTH is cheaper than 93.05% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.55. LNTH is valued rather cheaply when compared to this.
LNTH is valuated reasonably with a Price/Forward Earnings ratio of 11.55.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 92.51% of the companies listed in the same industry.
LNTH is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.78, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.95 | ||
| Fwd PE | 11.55 |
4.2 Price Multiples
88.77% of the companies in the same industry are more expensive than LNTH, based on the Enterprise Value to EBITDA ratio.
96.26% of the companies in the same industry are more expensive than LNTH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.45 | ||
| EV/EBITDA | 11.22 |
4.3 Compensation for Growth
LNTH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.26
EPS Next 2Y-8.73%
EPS Next 3Y-0.06%
5. Dividend
5.1 Amount
LNTH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:LNTH (12/16/2025, 12:22:31 PM)
65.24
-1.33 (-2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners110.67%
Inst Owner Change-11.53%
Ins Owners0.78%
Ins Owner Change1.05%
Market Cap4.33B
Revenue(TTM)1.53B
Net Income(TTM)167.68M
Analysts80
Price Target82.54 (26.52%)
Short Float %10.95%
Short Ratio5.41
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.75%
Min EPS beat(2)-7.97%
Max EPS beat(2)-1.53%
EPS beat(4)1
Avg EPS beat(4)-4.39%
Min EPS beat(4)-9.67%
Max EPS beat(4)1.61%
EPS beat(8)4
Avg EPS beat(8)1.42%
EPS beat(12)8
Avg EPS beat(12)7.49%
EPS beat(16)12
Avg EPS beat(16)17.76%
Revenue beat(2)1
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-4.74%
Max Revenue beat(2)3.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-4.74%
Max Revenue beat(4)3.61%
Revenue beat(8)5
Avg Revenue beat(8)0.49%
Revenue beat(12)8
Avg Revenue beat(12)1.45%
Revenue beat(16)12
Avg Revenue beat(16)4.07%
PT rev (1m)-2.95%
PT rev (3m)-10.24%
EPS NQ rev (1m)-3.4%
EPS NQ rev (3m)-8.59%
EPS NY rev (1m)-0.7%
EPS NY rev (3m)-2.13%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)1.39%
Revenue NY rev (3m)1.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.95 | ||
| Fwd PE | 11.55 | ||
| P/S | 2.84 | ||
| P/FCF | 10.45 | ||
| P/OCF | 9.45 | ||
| P/B | 3.87 | ||
| P/tB | 30.99 | ||
| EV/EBITDA | 11.22 |
EPS(TTM)5.96
EY9.14%
EPS(NY)5.65
Fwd EY8.66%
FCF(TTM)6.24
FCFY9.57%
OCF(TTM)6.9
OCFY10.58%
SpS23.01
BVpS16.88
TBVpS2.11
PEG (NY)N/A
PEG (5Y)0.26
Graham Number47.58
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.37% | ||
| ROE | 14.98% | ||
| ROCE | 17.9% | ||
| ROIC | 13.6% | ||
| ROICexc | 16.96% | ||
| ROICexgc | 46.21% | ||
| OM | 22.63% | ||
| PM (TTM) | 10.99% | ||
| GM | 62.23% | ||
| FCFM | 27.13% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
ROICexc(3y)32.43%
ROICexc(5y)N/A
ROICexgc(3y)46.23%
ROICexgc(5y)N/A
ROCE(3y)21.38%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y26.32%
ROICexc growth 3YN/A
ROICexc growth 5Y20.97%
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
F-Score5
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.51 | ||
| Debt/FCF | 1.37 | ||
| Debt/EBITDA | 1.39 | ||
| Cap/Depr | 67.65% | ||
| Cap/Sales | 2.86% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 111.66% | ||
| Profit Quality | 246.91% | ||
| Current Ratio | 2.67 | ||
| Quick Ratio | 2.49 | ||
| Altman-Z | 4.15 |
F-Score5
WACC8.06%
ROIC/WACC1.69
Cap/Depr(3y)104.83%
Cap/Depr(5y)78.74%
Cap/Sales(3y)4.75%
Cap/Sales(5y)4.15%
Profit Quality(3y)383.97%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.12%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-25.29%
EPS Next Y-15.93%
EPS Next 2Y-8.73%
EPS Next 3Y-0.06%
EPS Next 5Y2.96%
Revenue 1Y (TTM)1.95%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%1.39%
Revenue Next Year-1.03%
Revenue Next 2Y0.1%
Revenue Next 3Y4.21%
Revenue Next 5Y5.41%
EBIT growth 1Y-27.19%
EBIT growth 3YN/A
EBIT growth 5Y54.05%
EBIT Next Year-15.04%
EBIT Next 3Y-0.56%
EBIT Next 5YN/A
FCF growth 1Y59.73%
FCF growth 3Y123.25%
FCF growth 5Y51.49%
OCF growth 1Y53.38%
OCF growth 3Y116.21%
OCF growth 5Y46.62%
LANTHEUS HOLDINGS INC / LNTH FAQ
What is the fundamental rating for LNTH stock?
ChartMill assigns a fundamental rating of 7 / 10 to LNTH.
What is the valuation status for LNTH stock?
ChartMill assigns a valuation rating of 8 / 10 to LANTHEUS HOLDINGS INC (LNTH). This can be considered as Undervalued.
How profitable is LANTHEUS HOLDINGS INC (LNTH) stock?
LANTHEUS HOLDINGS INC (LNTH) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for LNTH stock?
The Price/Earnings (PE) ratio for LANTHEUS HOLDINGS INC (LNTH) is 10.95 and the Price/Book (PB) ratio is 3.87.
What is the earnings growth outlook for LANTHEUS HOLDINGS INC?
The Earnings per Share (EPS) of LANTHEUS HOLDINGS INC (LNTH) is expected to decline by -15.93% in the next year.